HIGH

USV Private Olopatadine Eye Drops 0.1% Recalled in 8,952 Bottles (2025)

USV Private recalled 8,952 bottles of Olopatadine Hydrochloride Ophthalmic Solution USP 0.1%. The product was distributed nationwide in the United States. The defect is failure of impurities/degradation specifications due to an unspecified impurity exceeding the limit. Stop using immediately and contact USV Private Limited or a healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
October 9, 2025
Hazard Level
HIGH
Brand
USV Private
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact USV Private Limited or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Olopatadine hydrochloride ophthalmic solution is used to treat allergic conjunctivitis by reducing itching in the eyes.

Why This Is Dangerous

The product failed impurity/degradation specifications due to an unspecified impurity exceeding the limit. The exact health impact is not detailed in the recall.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers may face unknown health risks from the impurity. The recall affects nearly 9,000 bottles, requiring immediate discontinuation of use and guidance from a healthcare provider.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 70512-0520-05 on the bottle.
  2. Check Lot 35000409.
  3. Confirm Exp 01/2026.
  4. confirm bottle size is 5 mL.

Where to find product info

Label on bottle and external packaging showing NDC, Lot, Exp date; FDA recall page for D-0034-2026.

What timeline to expect

Refunds or replacements are typically processed within 4-8 weeks after confirmation of eligibility.

If the manufacturer is unresponsive

  • File a complaint with the FDA if the company is unresponsive.
  • Consider state consumer protection or other regulatory channels.
  • Consult your healthcare provider for interim guidance.

How to prevent similar issues

  • Always verify NDC codes before purchasing new ophthalmic solutions.
  • Keep recall notices and packaging until the case is resolved.
  • Ask for official recall letters and track updates from the manufacturer and FDA.

Documentation advice

Keep the recall letter, photos of the bottle labeling, and all communications with the company. Preserve the bottle and packaging for reference.

Product Details

Product: Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% 5 mL (0.17 FL OZ) bottles NDC: 70512-0520-05 Lot: 35000409 Exp: 01/2026 Quantity: 8,952 bottles Distributor/Manufacturer: SOLA PHARMACEUTICS LLC, Baton Rouge, LA 70810 Sold nationwide in the United States Price: Not provided

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 8,952 bottles recalled
  • NDC 70512-0520-05
  • Lot 35000409
  • Exp 01/2026
  • 5 mL bottles
  • Nationwide US distribution

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONINGOTHER

Product Details

Model Numbers
35000409
Affected States
ALL
Report Date
October 29, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more